TY - STD TI - Torre LA, Bray F, Siegel RL, Ferlay J, Lortet- Tieulent J, Jemal A. Global Cancer Statistics 2012 CA. Cancer J Clin. 2015;65:87–108. ID - ref1 ER - TY - JOUR AU - Wee, J. AU - Tan, E. H. AU - Tai, B. C. AU - Wong, H. B. AU - Leong, S. S. AU - Tan, T. PY - 2005 DA - 2005// TI - Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.16.790 DO - 10.1200/JCO.2005.16.790 ID - Wee2005 ER - TY - JOUR AU - Yarney, J. AU - Vanderpuye, V. AU - Kitcher, E. D. PY - 2008 DA - 2008// TI - Treatment outcome of locally advanced nasopharyngeal cancer with concurrent chemoradiotherapy JO - West Afr J Med VL - 27 ID - Yarney2008 ER - TY - JOUR AU - Chan, K. C. AU - Hung, E. C. AU - Woo, J. K. AU - Chan, P. K. AU - Leung, S. F. AU - Lai, F. P. PY - 2013 DA - 2013// TI - Early detection of nasopharyngeal carcinoma by plasma Epstein Barr virus DNA analysis in a surveillance programme JO - Cancer VL - 119 UR - https://doi.org/10.1002/cncr.28001 DO - 10.1002/cncr.28001 ID - Chan2013 ER - TY - JOUR AU - Taylor, G. S. AU - Jia, H. AU - Harrington, K. AU - Lee, L. W. AU - Turner, J. AU - Ladell, K. PY - 2014 DA - 2014// TI - A recombinant modified vaccinia Ankara vaccine encoding Epstein- Barr virus targeted antigens: a phase 1 trial in UK patients with EBV-positive cancer JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-14-1122-T DO - 10.1158/1078-0432.CCR-14-1122-T ID - Taylor2014 ER - TY - JOUR AU - Al-Sarraf, M. AU - LeBlanc, M. AU - Giri, P. G. AU - Fu, K. K. AU - Cooper, J. AU - Vuong, T. PY - 1998 DA - 1998// TI - Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099 JO - J Clin Oncol VL - 16 UR - https://doi.org/10.1200/JCO.1998.16.4.1310 DO - 10.1200/JCO.1998.16.4.1310 ID - Al-Sarraf1998 ER - TY - JOUR AU - Baujat, B. AU - Audry, H. AU - Bourhis, J. AU - Chan, A. T. AU - Onat, H. AU - Chua, D. T. PY - 2006 DA - 2006// TI - Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients JO - Int J Radiat Oncol Biol Phys VL - 4 UR - https://doi.org/10.1016/j.ijrobp.2005.06.037 DO - 10.1016/j.ijrobp.2005.06.037 ID - Baujat2006 ER - TY - JOUR AU - Langendijk, J. A. AU - Leemans, C. R. AU - Buter, J. AU - Berkhof, J. AU - Slotman, B. J. PY - 2004 DA - 2004// TI - The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.10.074 DO - 10.1200/JCO.2004.10.074 ID - Langendijk2004 ER - TY - JOUR AU - Blanchard, P. AU - Lee, A. AU - Marguet, S. AU - Leclercq, J. AU - Ng, W. T. AU - Ma, J. PY - 2015 DA - 2015// TI - Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis JO - Lancet Oncol VL - 16 UR - https://doi.org/10.1016/S1470-2045(15)70126-9 DO - 10.1016/S1470-2045(15)70126-9 ID - Blanchard2015 ER - TY - JOUR AU - Chua, D. T. AU - Ma, J. AU - Sham, J. S. AU - Mai, H. Q. AU - Choy, D. T. AU - Hong, M. H. PY - 2005 DA - 2005// TI - Long- term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.12.081 DO - 10.1200/JCO.2005.12.081 ID - Chua2005 ER - TY - JOUR AU - Fountzilas, G. AU - Ciuleanu, E. AU - Bobos, M. AU - Kalogera-Fountzila, A. AU - Eleftheraki, A. G. AU - Karayannopoulou, G. PY - 2012 DA - 2012// TI - Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation JO - Ann Oncol VL - 23 UR - https://doi.org/10.1093/annonc/mdr116 DO - 10.1093/annonc/mdr116 ID - Fountzilas2012 ER - TY - JOUR AU - Hui, E. P. AU - Ma, B. B. AU - Leung, S. F. AU - King, A. D. AU - Mo, F. AU - Kam, M. K. PY - 2009 DA - 2009// TI - Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.18.1545 DO - 10.1200/JCO.2008.18.1545 ID - Hui2009 ER - TY - JOUR AU - Al- Amro, A. AU - Rajhi, N. AU - Khfaga, Y. AU - Memon, M. AU - Hebshi, A. AU - El-Enbabi, A. PY - 2005 DA - 2005// TI - Neoadjuvant chemotherapy followed by concurrent chemo-radiation in locally advanced nasopharyngeal cancer JO - Int J Rad Oncol VL - 62 UR - https://doi.org/10.1016/j.ijrobp.2004.09.050 DO - 10.1016/j.ijrobp.2004.09.050 ID - Al- Amro2005 ER - TY - JOUR AU - Chen, L. AU - Hu, C. S. AU - Chen, X. Z. AU - Hu, G. Q. AU - Cheng, Z. B. AU - Sun, Y. PY - 2012 DA - 2012// TI - Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multi-centre randomized controlled trial JO - Lancet Oncol VL - 13 UR - https://doi.org/10.1016/S1470-2045(11)70320-5 DO - 10.1016/S1470-2045(11)70320-5 ID - Chen2012 ER - TY - JOUR AU - Kao, W. C. AU - Chen, J. -. S. AU - Yen, C. -. J. PY - 2016 DA - 2016// TI - Advanced nasopharyngeal carcinoma in children JO - J Cancer Res Pract VL - 3 UR - https://doi.org/10.1016/j.jcrpr.2016.05.007 DO - 10.1016/j.jcrpr.2016.05.007 ID - Kao2016 ER - TY - JOUR AU - Liu, W. AU - Tang, Y. AU - Gao, L. AU - Huang, X. AU - Luo, J. AU - Zhang, S. PY - 2014 DA - 2014// TI - Nasopharyngeal carcinoma in children and adolescents-a single institution experience of 158 patients Radiation JO - Oncology VL - 9 ID - Liu2014 ER - TY - JOUR AU - Ayan, I. AU - Kaytan, E. AU - Ayan, N. PY - 2003 DA - 2003// TI - Childhood nasopharyngeal carcinoma: from biology to treatment JO - Lancet Oncol VL - 4 UR - https://doi.org/10.1016/S1470-2045(03)00956-2 DO - 10.1016/S1470-2045(03)00956-2 ID - Ayan2003 ER - TY - JOUR AU - Chen, Y. P. AU - Guo, R. AU - Liu, N. AU - Liu, X. AU - Mao, Y. P. AU - Tang, L. -. L. PY - 2015 DA - 2015// TI - Efficacy of the additional neoadjuvant chemotherapy to concurrent chemoradiotherapy for patients with locoregionally advanced nasopharyngeal carcinoma: a Bayesian network meta- analysis of randomized controlled trials JO - J Cancer VL - 6 UR - https://doi.org/10.7150/jca.11814 DO - 10.7150/jca.11814 ID - Chen2015 ER - TY - JOUR AU - Song, J. H. AU - Wu, H. -. G. AU - Keam, B. S. AU - Han, J. H. AU - Ahn, Y. C. AU - Oh, D. PY - 2016 DA - 2016// TI - The role of neoadjuvant chemotherapy in the treatment of nasopharyngeal carcinoma: a multi-institutional retrospective study (KROG 11–06) using propensity score matching analysis JO - Cancer Res Treat VL - 48 UR - https://doi.org/10.4143/crt.2015.265 DO - 10.4143/crt.2015.265 ID - Song2016 ER - TY - JOUR AU - Sun, Y. AU - Li, W. -. F. AU - Chen, N. -. Y. AU - Zhang, N. AU - Hu, G. -. Q. AU - Xie, F. -. Y. PY - 2016 DA - 2016// TI - Induction chemotherapy plus concurrent chemotherapy versus concurrent chemotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicenter randomized controlled trial JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30410-7 DO - 10.1016/S1470-2045(16)30410-7 ID - Sun2016 ER - TY - JOUR AU - Golden, D. W. AU - Rudra, S. AU - Witt, M. E. AU - Nwizu, T. AU - Cohen, E. E. W. AU - Blair, E. PY - 2013 DA - 2013// TI - Outcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal cancer JO - Oral Oncol VL - 49 UR - https://doi.org/10.1016/j.oraloncology.2012.10.003 DO - 10.1016/j.oraloncology.2012.10.003 ID - Golden2013 ER - TY - JOUR AU - Kong, L. AU - Hu, C. AU - Niu, X. AU - Zhang, Y. AU - Guo, Y. AU - Tham, I. W. PY - 2013 DA - 2013// TI - Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma: Interim results from two prospective phase 2 clinical trials JO - Cancer VL - 119 UR - https://doi.org/10.1002/cncr.28324 DO - 10.1002/cncr.28324 ID - Kong2013 ER - TY - STD TI - Tan T, Lim WT, Fong KW, Cheah SL, Soong YL, Ang MK et al. Randomized phase III trial of concurrent chemoradiation with or without neoadjuvant gemcitabine, carboplatin, and paclitaxel in locally advanced nasopharyngeal cancer. J ClinOncol 32:5 s, 2014(suppl; abstr 6003). ID - ref23 ER - TY - JOUR AU - Wu, S. Y. AU - Wu, Y. H. AU - Yang, M. W. AU - Hsueh, W. T. AU - Hsiao, J. R. AU - Tsai, S. T. PY - 2014 DA - 2014// TI - Comparison of concurrent chemoradiotherapy versus neoadjuvant chemotherapy followed by radiation in patients with advanced nasopharyngeal carcinoma in endemic area: experience of 128 consecutive cases with 5-year follow-up JO - BMC Cancer VL - 14 UR - https://doi.org/10.1186/1471-2407-14-787 DO - 10.1186/1471-2407-14-787 ID - Wu2014 ER -